ChemicalBook > Product Catalog >Biochemical Engineering >Nucleoside drugs >Nucleotides and their analogs >N4-Benzoylcytosine
N4-Benzoylcytosine
- CAS No.
- 26661-13-2
- Chemical Name:
- N4-Benzoylcytosine
- Synonyms
- N3333-FSI;N-Benzoylcytosine;4-BENZOYLCYTOSINE;N4-BENZOYLCYTOSINE;Atrazine Impurity 7;LABOTEST-BB LT00138031;N4-Benzoylcytosine 98%;N4-Benzoylcytosine >Sofosbuvir Impurity 141;N4-Benzoylcytosine USP/EP/BP
- CBNumber:
- CB4118859
- Molecular Formula:
- C11H9N3O2
- Molecular Weight:
- 215.21
- MOL File:
- 26661-13-2.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/11/16 17:07:08
Melting point | >300 °C (dec.) (lit.) |
---|---|
Density | 1.33±0.1 g/cm3(Predicted) |
vapor pressure | 0Pa at 25℃ |
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
solubility | Aqueous Acid (Slightly, Heated), DMSO+DCl (Slightly, Heated) |
pka | 7.75±0.10(Predicted) |
form | Solid |
color | Off-White |
InChI | InChI=1S/C11H9N3O2/c15-10(8-4-2-1-3-5-8)13-9-6-7-12-11(16)14-9/h1-7H,(H2,12,13,14,15,16) |
InChIKey | XBDUZBHKKUFFRH-UHFFFAOYSA-N |
SMILES | C(NC1=CC=NC(=O)N1)(=O)C1=CC=CC=C1 |
Surface tension | 72.2mN/m at 1g/L and 21.2℃ |
CAS DataBase Reference | 26661-13-2(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302+H332-H315-H319-H335 | |||||||||
Precautionary statements | P261-P264-P301+P312-P302+P352-P304+P340+P312-P305+P351+P338 | |||||||||
Hazard Codes | Xi | |||||||||
Risk Statements | 20/22-36/37/38 | |||||||||
Safety Statements | 26-36 | |||||||||
WGK Germany | 3 | |||||||||
HS Code | 29335990 | |||||||||
NFPA 704 |
|
N4-Benzoylcytosine price More Price(2)
N4-Benzoylcytosine Chemical Properties,Uses,Production
Chemical Properties
White or almost white crystalline powder
Uses
N4-Benzoylcytosine may be employed for the following syntheses:
- 3′-C-ethynyl and 3′-C-(1,4-disubstituted-1,2,3-triazolo) double-headed pyranonucleosides
- 2′-C-methyl-4′-thiocytidine, via the Pummerer reaction
- 2′-fluorinated L-nucleoside analogs
General Description
N4-Benzoylcytosine is an amide and its anti-microbial activity against pathogenic microorganisms has been studied using the Disk Diffusion and the Pour Plate method. It can be synthesized via the condensation of benzoyl chloride with cytosine.
N4-Benzoylcytosine Preparation Products And Raw materials
Raw materials
chevron_left
1of3
chevron_rightPreparation Products
Global( 437)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
GLR Innovations | +91 9891111994 | New Delhi, India | 4542 | 58 | Inquiry |
Vibrant Life Sciences | +917989177519 | Telangana, India | 26 | 58 | Inquiry |
Trimax bio sciences private ltd | +91-8532299988 +91-8532299988 | Karnataka, India | 36 | 58 | Inquiry |
Merix Laboratories Pvt Ltd | +91-7893336376 +91-7893336376 | Telangana, India | 50 | 58 | Inquiry |
Blue Jet Healthcare Ltd | +91-02222071691 +91-9082861262 | Mumbai, India | 86 | 58 | Inquiry |
OctaneX Labs | 91-40-29556999 | Hyderabad, India | 101 | 58 | Inquiry |
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
Survival Technologies Pvt., Ltd. (STPL) | 91-22-61902008 | Maharashtra, India | 119 | 58 | Inquiry |
Trignokem International | +91-40-2374 0789 | Andhra Pradesh, India | 110 | 58 | Inquiry |
Clearsynth Labs | 91-22-45045900 | Maharashtra, India | 3889 | 58 | Inquiry |
Supplier | Advantage |
---|---|
GLR Innovations | 58 |
Vibrant Life Sciences | 58 |
Trimax bio sciences private ltd | 58 |
Merix Laboratories Pvt Ltd | 58 |
Blue Jet Healthcare Ltd | 58 |
OctaneX Labs | 58 |
A.J Chemicals | 58 |
Survival Technologies Pvt., Ltd. (STPL) | 58 |
Trignokem International | 58 |
Clearsynth Labs | 58 |
26661-13-2(N4-Benzoylcytosine)Related Search:
Dihydromyrcenol
Propanamide, N-(6,7-dihydro-6-oxo-1H-purin-2-yl)-2-methyl-
N-ALLYLBENZYLAMINE
N-Allylmethylamine
3-Pyridinecarboxamide, 5-chloro-N-methyl-
2'-deoxy-2'-fluoro-2'-C-methylcytidine
2'-C-Methyl-, 2',3',5'-tribenzoateuridine
(2R)-2-Deoxy-2-fluoro-2-Methyl-D-erythro-pentonic acid-g-lactone 3,5-bis(4-chlorobenzoate)
((2R,3S,4S)-3-(benzoyloxy)-4-fluoro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate
3-Pyridinecarboxamide, 4-chloro-N-methyl-
chevron_left
1of4
chevron_right
N4-Benzoylcytosine
N4-Benzoylcytosine≥ 99% (HPLC)
N-(2-Oxo-3H-pyrimidin-4-yl)benzamide
n-(2-oxo-1,2-dihydro-4-pyrimidinyl)benzamide
N4-BENZOYLCYTOSINE
LABOTEST-BB LT00138031
N-Benzoylcytosine
N-(2-keto-1H-pyrimidin-6-yl)benzamide
N-(2-oxo-1H-pyrimidin-6-yl)benzamide
N-(2-oxo-2,3-dihydropyriMidin-4-yl)benzaMide
N-(2-Oxo-1,2-dihydro-pyriMidin-4-yl)-benzaMide
4-BENZOYLCYTOSINE
N4-Benzoylcytosine 98%
Benzamide, N-(2,3-dihydro-2-oxo-4-pyrimidinyl)-
N4-Benzoylcytosine >
N-(2-Hydroxy-pyrimidin-4-yl)-benzamide
N4-Benzoylcytosine USP/EP/BP
N3333-FSI
N4-BenzoylcytosineQ: What is
N4-Benzoylcytosine Q: What is the CAS Number of
N4-Benzoylcytosine Q: What is the storage condition of
N4-Benzoylcytosine Q: What are the applications of
N4-Benzoylcytosine
Dimethyloldimethyl hydantoin 6440-58-0
Sofosbuvir Impurity 141
Atrazine Impurity 7
26661-13-2
C11H9N3O2
Building Blocks
Heterocyclic Building Blocks
Pyrimidines
Heterocyclic Compounds
Building Blocks
Heterocyclic Building Blocks
Pyrimidines